angiotensin ii, des-phe(8)- has been researched along with citrulline in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (citrulline) | Trials (citrulline) | Recent Studies (post-2010) (citrulline) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 4,572 | 195 | 1,537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, J; Li, J; Lu, J; Xing, J | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and citrulline
| Article | Year |
|---|---|
Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway.
Topics: Angiotensin I; Animals; Citrulline; Female; Male; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Peptide Fragments; Periaqueductal Gray; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Thiourea | 2012 |